News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EAS 2021 Lp(a) Not Associated With Ongoing Aortic Valve Calcification Michael O'Riordan June 04, 2021
News Conference News EAS 2021 For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short Michael O'Riordan June 03, 2021
News Conference News EAS 2016 Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI Yael L. Maxwell June 08, 2016